The DEA grants a one-year extension on telehealth prescription of addiction medications, kicking resolution on a fraught issue to the second Trump administration.
FDA’s requirement for truthful, balanced risk and benefit information applies to drugmakers, leaving a loophole for both ...
Recent developments driving growth in this area make the advanced, AI-supported digitization of pharma pipelines inevitable.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback